Restylane family guides, comparisons, product selection, longevity, cost, and filler risk.
US Belotero duration is PMA- and area-specific. Healthline mixes EU SKUs. Intense P250016 is lips, not EU deep folds. Volume is 48-week cheeks versus Lyft, not Voluma's…
RHA duration is PMA- and area-specific. Manufacturer up-to-15-months is a 64-week NLF follow-up, not a median. Dynamic Volume midface is S048 18 Sep 2025, not the 13 Jan…
How long Restylane lasts is product- and area-specific PMA data. Manufacturer up-to numbers are ceilings with touch-up, not medians. Contour is not Lyft.
FDA approved RHA Redensity Eye on 12 May 2026 for infraorbital hollows. It is a 15 mg/g gel, the fourth on-label HA, not the first under-eye filler.
Which hyaluronic-acid fillers are actually FDA-approved for the chin, how they differ from Volux jawline filler, and when an implant or Kybella is the better next step.
Sunken temples can age the upper face, but vascular safety is critical. We analyze Juvéderm Voluma, Restylane Contour, off-label biostimulators, and FDA MAUDE safety…
A clinical and economic guide comparing dermal fillers, Sculptra, fat transfer, and malar implants for midface volume restoration, featuring ASPS data and FDA approval…
A regulatory and clinical dossier profiling Galderma's aesthetic portfolio, its 250 FDA PMA supplements under Q-Med AB, Dysport BLA history, and MAUDE/FAERS safety…
A clinical, evidence-first comparison of the only two FDA-approved dermal fillers for hand rejuvenation, reviewing chemical mechanisms, pivotal trials, and safety…
20 original PMA approvals since 1981, 1,036 total PMA records, and a recent wave of new entrants: what the FDA premarket-approval database reveals about who makes the…